Member Info for Mars1

It makes sense it is a new test. The Surescreen test has been around for sometime and there has been a delay which ties in with the explanation given by ODX in the revision to the Mologic test. Also it ties in with ODX saying news expected in July only 3 days late. Also that ODX and Mologic are two of the three suppliers and finally the self test labelling for the Visitect test all ties in.

Imminent minus just means news can drop at any time
https://m.youtube.com/watch?v=D5Y11hwjMNs

In addition to the govt supplied LFT packer on Monday as confirmed by ODX there was today a new delivery of a Belt XP22 compressed air machine which are used in the production of LFTs. So increased production from April 2m a week.

Very clear timeline for NXP002 and NXP004 results if it is big pharma lined up to pull the trigger might just shoot back and buy NFX

Non execs are rarely on 6 months notice, more likely one month, but Blackwell left for personal reasons ie of his own accord therefore no compensation.

Garden leave and restrictions to work us usually only apply in highly competitive industries, pharma development is much longer term, so he may have been paid for his contract term but not restricted from working elsewhere

Fix Dan May have been on 6 months notice therefore would have been paid for that period. But of course all guesswork

CV gives a wide range of ex colleagues including Glaxo and AZ
Anne was previously CEO of Advent Pharmaceuticals Pty Ltd, Melbourne, Australia, a specialty R&D company focused on generic inhaled products for global markets. In that role, Anne led a successful sale of the products and assets to AuroScience Pty Ltd, Melbourne, Australia, a wholly owned subsidiary of Aurobindo Pharma USA Inc. She subsequently became CEO of AuroScience Pty Ltd.



Before moving to Advent, Anne was a Board member and Managing Director of Respivert Ltd, a subsidiary of Janssen Pharmaceuticals (part of Johnson & Johnson, Inc), where she was responsible for leadership and operations of the company, including discovery / development programmes spanning three novel classes of drug for idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease and asthma, as well as out-licensing activities. Prior to this, Anne occupied the role of Vice President and Head of Inhalation Products.



Anne's earlier career included roles as Executive Vice President, Pharmaceutical Development & Project Management at Skyepharma plc, a specialty pharma company developing innovative oral and inhalation products, and senior positions in Product Development at AstraZeneca PLC. Prior to this, Anne worked at GlaxoSmithKline plc.

Anyone selling is being turned over at these levels with so much news on the way

Buy 140k after hours filled during day with ave price, but well above bid. MMS holding price to fill?!

Not the group you wouldn’t but a U.K. subsidiary is a possibility would have depended upon the reporting structure at the time ie awareness of the senior management and also where your ex-colleagues are now in the organisation. However an organisation that big you would not need to be an MD to still obtain a dream job.

FF I was thinking U.K. MD for Johnson & Johnson working on the other side of the NFX fibrosis project, see her cv for past colleagues, this part is interesting (Managing Director of Respivert Ltd, a subsidiary of Janssen Pharmaceuticals (part of Johnson & Johnson, Inc), where she was responsible for leadership and operations of the company, including discovery / development programmes spanning three novel classes of drug for idiopathic pulmonary fibrosis, )

I have done it myself in the past, recruited a head of accounting from a business run by a good acquaintance, had to buy him (MD) lunch as an apology, got back to work, cleared it with HR, phoned the MD that afternoon and offered him a job, he had no idea at lunch time that I needed more senior people. It was an interesting conversation.

Chairman’s letter today was very clear, there was no doubt things are moving forward and the reason Anne resigned, as they knew her, ex-colleagues there would be no need for an interview, just a phone call, this is what we are doing we need someone here is the offer are you interested full stop, quick and easy.

Sorry cannot keep up busy so will not be able to continue atm. FX fibrosis because that will be what counterpart y will be signing up for. Soup yes agree 6 months is normal for senior exec, can be waived if parties agree, so may or may not have been requested, I guess the latter.

Think Anne will be truly professional, another gong on the cv, if she can close a deal before she leaves.

Would also explain why they can wait 6 months

To go a step further it may be why one of the parties need her to run a new fibrosis project

It may even be one of the parties which is why she was speaking to past colleagues

If they are already in discussions they would have spoken to them prior to issuing the announcement